首页> 外文期刊>Cell Calcium: The International Interdisciplinary Forum for Research on Calcium >Exogenous nitric oxide triggers classic ischemic preconditioning by preventing intracellular Ca2+ overload in cardiomyocytes.
【24h】

Exogenous nitric oxide triggers classic ischemic preconditioning by preventing intracellular Ca2+ overload in cardiomyocytes.

机译:外源性一氧化氮可通过防止心肌细胞内细胞内Ca2 +超负荷来触发经典的缺血预处理。

获取原文
获取原文并翻译 | 示例
           

摘要

The involvement of nitric oxide (NO) in the late phase of ischemic preconditioning is well established. However, the role of NO as a trigger or mediator of "classic preconditioning" remains to be determined. The present study was designed to investigate the effects of NO on calcium homeostasis in cultured newborn rat cardiomyocytes in normoxia and hypoxia. We found that treatment with the NO donor, sodium nitroprusside (SNP) induced a sustained elevation of intracellular calcium level ([Ca(2+)](i)) followed by a decrease to control levels. Elevation of extracellular calcium, which generally occurs during ischemia, caused an immediate increase in [Ca(2+)](i) and arrhythmia in cultures of newborn cardiomyocytes. Treatment with SNP decreased [Ca(2+)](i) to control levels and re-established synchronized beating of cardiomyocytes. A decrease in extracellular [Na(+)], which inhibits the Na(+)/Ca(2+) exchanger, did not prevent [Ca(2+)](i) reduction by SNP. In contrast, application of thapsigargin, an inhibitor of sarcoplasmic reticulum Ca(2+)-ATPase (SERCA2a), increased [Ca(2+)](i), and in its presence, SNP did not reduce [Ca(2+)](i), indicating that Ca(2+) reduction is achieved via activation of SERCA2a. The results obtained suggest that activation of SERCA2a by SNP increases Ca(2+) uptake into the sarcoplasmic reticulum (SR) and prevents cytosolic Ca(2+) overload, which might explain the protective effect of SNP from hypoxic damage.
机译:一氧化氮(NO)参与缺血预处理的后期阶段已经很成熟。然而,NO作为“经典预处理”的触发或调节者的作用仍有待确定。本研究旨在研究常氧和低氧条件下NO对培养的新生大鼠心肌细胞钙稳态的影响。我们发现用NO供体硝普钠(SNP)的治疗诱导细胞内钙水平([Ca(2 +)](i))的持续升高,然后降低至对照水平。通常在局部缺血期间发生的细胞外钙的升高引起[Ca(2 +)](i)的立即增加和新生心肌细胞培养物中的心律不齐。 SNP治疗降低[Ca(2 +)](i)达到控制水平并重新建立心肌细胞的同步跳动。细胞外[Na(+)]的减少,它抑制Na(+)/ Ca(2+)交换器,并不能防止[Ca(2 +)](i)SNP的减少。相比之下,thapsigargin,肌浆网Ca(2 +)-ATPase(SERCA2a)的抑制剂的应用,增加了[Ca(2 +)](i),并且在其存在下,SNP不会降低[Ca(2+) ](i),表明Ca(2+)的减少是通过激活SERCA2a实现的。获得的结果表明,SNP激活SERCA2a增加了Ca(2+)对肌浆网(SR)的吸收,并防止了胞质Ca(2+)超载,这可能解释了SNP对低氧损伤的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号